No Data
Insider Purchase: President & CEO of $GRF (GRF) Buys 1,000 Shares
Eagle Capital Growth Fund Inc To Go Ex-Dividend On November 29th, 2024 With 0.68 USD Dividend Per Share
Grifols completed the sale of 20% of Shanghai RAAS Blood Products shares and reached a global strategy cooperation agreement with Haier Group.
With today's completed trade announcement, Grifols and Haier will collaborate through Shanghai RAAS to enhance China's medical care system. Through a stock purchase agreement, Grifols is selling 20% of Shanghai RAAS's shares to Haier Group for RMB 12.5 billion (approximately 1.6 billion euros). Grifols and Shanghai RAAS have extended their exclusive agent agreement for albumin for the next 10 years, and Shanghai RAAS can choose to extend it until 2044. All of Grifols' earnings will be used to fulfill its deleveraging commitments. Shanghai, June 18, 2024 / PR Newswire / - Global medical and health enterprises.
Eagle Capital Growth Fund Inc(GRF.US) Director Buys US$5,574 in Common Stock
Eagle Capital Growth Fund Inc(GRF.US) Officer Sells US$45,950 in Common Stocks
Eagle Capital Growth Fund Inc(GRF.US) Officer Buys US$47,172.27 in Common Stocks
